nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—GRIA4—nerve—peripheral nervous system neoplasm	0.017	0.0775	CbGeAlD
Topiramate—GRIA4—ganglion—peripheral nervous system neoplasm	0.0168	0.0766	CbGeAlD
Topiramate—GRIK1—nerve—peripheral nervous system neoplasm	0.0149	0.068	CbGeAlD
Topiramate—GRIK1—ganglion—peripheral nervous system neoplasm	0.0148	0.0671	CbGeAlD
Topiramate—GRIA3—nerve—peripheral nervous system neoplasm	0.0139	0.0632	CbGeAlD
Topiramate—GRIK5—trigeminal ganglion—peripheral nervous system neoplasm	0.00763	0.0347	CbGeAlD
Topiramate—GRIK3—trigeminal ganglion—peripheral nervous system neoplasm	0.00763	0.0347	CbGeAlD
Topiramate—GRIA1—nerve—peripheral nervous system neoplasm	0.00742	0.0337	CbGeAlD
Topiramate—GRIA1—ganglion—peripheral nervous system neoplasm	0.00733	0.0333	CbGeAlD
Topiramate—GRIA4—brainstem—peripheral nervous system neoplasm	0.00732	0.0333	CbGeAlD
Topiramate—GRIK1—trigeminal ganglion—peripheral nervous system neoplasm	0.00725	0.033	CbGeAlD
Topiramate—GRIK5—brainstem—peripheral nervous system neoplasm	0.00675	0.0307	CbGeAlD
Topiramate—GRIK1—brainstem—peripheral nervous system neoplasm	0.00641	0.0292	CbGeAlD
Topiramate—GRIA2—ganglion—peripheral nervous system neoplasm	0.00582	0.0265	CbGeAlD
Topiramate—GRIK2—nerve—peripheral nervous system neoplasm	0.00532	0.0242	CbGeAlD
Topiramate—GRIK2—ganglion—peripheral nervous system neoplasm	0.00526	0.0239	CbGeAlD
Topiramate—GRIK4—cerebellum—peripheral nervous system neoplasm	0.00456	0.0208	CbGeAlD
Topiramate—CA1—nerve—peripheral nervous system neoplasm	0.00394	0.0179	CbGeAlD
Topiramate—GRIA4—cerebellum—peripheral nervous system neoplasm	0.00361	0.0164	CbGeAlD
Topiramate—CA6—parotid gland—peripheral nervous system neoplasm	0.00339	0.0154	CbGeAlD
Topiramate—GRIK5—cerebellum—peripheral nervous system neoplasm	0.00333	0.0151	CbGeAlD
Topiramate—GRIK3—cerebellum—peripheral nervous system neoplasm	0.00333	0.0151	CbGeAlD
Topiramate—GRIA1—brainstem—peripheral nervous system neoplasm	0.00318	0.0145	CbGeAlD
Topiramate—GRIK1—cerebellum—peripheral nervous system neoplasm	0.00316	0.0144	CbGeAlD
Topiramate—CA4—nerve—peripheral nervous system neoplasm	0.00308	0.014	CbGeAlD
Topiramate—CA4—ganglion—peripheral nervous system neoplasm	0.00304	0.0138	CbGeAlD
Topiramate—GRIA3—cerebellum—peripheral nervous system neoplasm	0.00294	0.0134	CbGeAlD
Topiramate—GRIA2—brainstem—peripheral nervous system neoplasm	0.00253	0.0115	CbGeAlD
Topiramate—SCN1A—brainstem—peripheral nervous system neoplasm	0.00231	0.0105	CbGeAlD
Topiramate—GRIK2—brainstem—peripheral nervous system neoplasm	0.00229	0.0104	CbGeAlD
Topiramate—GABRG2—trigeminal ganglion—peripheral nervous system neoplasm	0.00203	0.00925	CbGeAlD
Topiramate—GABRB2—brainstem—peripheral nervous system neoplasm	0.0018	0.00818	CbGeAlD
Topiramate—CA7—cerebellum—peripheral nervous system neoplasm	0.00162	0.00737	CbGeAlD
Topiramate—GABRA1—brainstem—peripheral nervous system neoplasm	0.00159	0.00723	CbGeAlD
Topiramate—GRIA1—cerebellum—peripheral nervous system neoplasm	0.00157	0.00714	CbGeAlD
Topiramate—CA9—cerebellum—peripheral nervous system neoplasm	0.00142	0.00647	CbGeAlD
Topiramate—CA4—parotid gland—peripheral nervous system neoplasm	0.00141	0.00641	CbGeAlD
Topiramate—CA4—brainstem—peripheral nervous system neoplasm	0.00132	0.00601	CbGeAlD
Topiramate—GRIA2—cerebellum—peripheral nervous system neoplasm	0.00125	0.00567	CbGeAlD
Topiramate—CA2—trigeminal ganglion—peripheral nervous system neoplasm	0.00124	0.00564	CbGeAlD
Topiramate—CA2—parotid gland—peripheral nervous system neoplasm	0.00117	0.00532	CbGeAlD
Topiramate—SCN1A—cerebellum—peripheral nervous system neoplasm	0.00114	0.00518	CbGeAlD
Topiramate—GRIK2—cerebellum—peripheral nervous system neoplasm	0.00113	0.00513	CbGeAlD
Topiramate—CA2—brainstem—peripheral nervous system neoplasm	0.0011	0.00499	CbGeAlD
Topiramate—GABRG2—cerebellum—peripheral nervous system neoplasm	0.000887	0.00404	CbGeAlD
Topiramate—GABRB2—cerebellum—peripheral nervous system neoplasm	0.000887	0.00404	CbGeAlD
Topiramate—GABRA1—cerebellum—peripheral nervous system neoplasm	0.000783	0.00356	CbGeAlD
Topiramate—CA4—cerebellum—peripheral nervous system neoplasm	0.000652	0.00297	CbGeAlD
Topiramate—CA2—cerebellum—peripheral nervous system neoplasm	0.000541	0.00246	CbGeAlD
Topiramate—GRIK2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000438	0.00489	CbGpPWpGaD
Topiramate—GRIK4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000434	0.00485	CbGpPWpGaD
Topiramate—GRIK5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000434	0.00485	CbGpPWpGaD
Topiramate—GRIK3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000403	0.00451	CbGpPWpGaD
Topiramate—GRIK1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000403	0.00451	CbGpPWpGaD
Topiramate—GRIA1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—peripheral nervous system neoplasm	0.000399	0.00446	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	0.000397	0.00444	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000382	0.00427	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.00037	0.00414	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000367	0.0041	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000366	0.00409	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—NTRK1—peripheral nervous system neoplasm	0.000364	0.00407	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000356	0.00398	CbGpPWpGaD
Topiramate—CA4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000352	0.00394	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00035	0.00391	CbGpPWpGaD
Topiramate—CA5A—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000345	0.00386	CbGpPWpGaD
Topiramate—CA6—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000345	0.00386	CbGpPWpGaD
Topiramate—GRIA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000343	0.00384	CbGpPWpGaD
Topiramate—CA2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000338	0.00378	CbGpPWpGaD
Topiramate—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000337	0.00377	CbGpPWpGaD
Topiramate—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000336	0.00376	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000335	0.00375	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000335	0.00374	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—BDNF—peripheral nervous system neoplasm	0.000333	0.00373	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000332	0.00371	CbGpPWpGaD
Topiramate—GRIK5—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000326	0.00365	CbGpPWpGaD
Topiramate—GRIK4—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000326	0.00365	CbGpPWpGaD
Topiramate—CA1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000324	0.00362	CbGpPWpGaD
Topiramate—CA7—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000322	0.0036	CbGpPWpGaD
Topiramate—CA5B—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000322	0.0036	CbGpPWpGaD
Topiramate—GRIK1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000303	0.00339	CbGpPWpGaD
Topiramate—GRIK3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000303	0.00339	CbGpPWpGaD
Topiramate—CA12—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000298	0.00334	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000285	0.00319	CbGpPWpGaD
Topiramate—CA9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000285	0.00318	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—IFNB1—peripheral nervous system neoplasm	0.00028	0.00313	CbGpPWpGaD
Topiramate—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—peripheral nervous system neoplasm	0.000279	0.00312	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	0.000269	0.00301	CbGpPWpGaD
Topiramate—GRIA4—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000258	0.00288	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000256	0.00287	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000254	0.00284	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000251	0.00281	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000251	0.00281	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	0.000251	0.00281	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00025	0.0028	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—HRAS—peripheral nervous system neoplasm	0.00025	0.0028	CbGpPWpGaD
Topiramate—GRIK4—Neuronal System—HRAS—peripheral nervous system neoplasm	0.00025	0.0028	CbGpPWpGaD
Topiramate—CA6—Metabolism—GNS—peripheral nervous system neoplasm	0.000249	0.00279	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GNS—peripheral nervous system neoplasm	0.000249	0.00279	CbGpPWpGaD
Topiramate—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000249	0.00279	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	0.000244	0.00272	CbGpPWpGaD
Topiramate—CA6—Metabolism—NME1—peripheral nervous system neoplasm	0.000239	0.00267	CbGpPWpGaD
Topiramate—CA5A—Metabolism—NME1—peripheral nervous system neoplasm	0.000239	0.00267	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	0.000238	0.00266	CbGpPWpGaD
Topiramate—CA4—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000238	0.00266	CbGpPWpGaD
Topiramate—CA7—Metabolism—GNS—peripheral nervous system neoplasm	0.000233	0.0026	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GNS—peripheral nervous system neoplasm	0.000233	0.0026	CbGpPWpGaD
Topiramate—GRIK1—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000232	0.0026	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000232	0.0026	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000232	0.0026	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00023	0.00258	CbGpPWpGaD
Topiramate—CA6—Metabolism—COX2—peripheral nervous system neoplasm	0.00023	0.00257	CbGpPWpGaD
Topiramate—CA5A—Metabolism—COX2—peripheral nervous system neoplasm	0.00023	0.00257	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.00023	0.00257	CbGpPWpGaD
Topiramate—CA2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000228	0.00255	CbGpPWpGaD
Topiramate—CA7—Metabolism—NME1—peripheral nervous system neoplasm	0.000223	0.0025	CbGpPWpGaD
Topiramate—CA5B—Metabolism—NME1—peripheral nervous system neoplasm	0.000223	0.0025	CbGpPWpGaD
Topiramate—CA1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000219	0.00245	CbGpPWpGaD
Topiramate—CA12—Metabolism—GNS—peripheral nervous system neoplasm	0.000216	0.00241	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	0.000215	0.00241	CbGpPWpGaD
Topiramate—CA5B—Metabolism—COX2—peripheral nervous system neoplasm	0.000215	0.0024	CbGpPWpGaD
Topiramate—CA7—Metabolism—COX2—peripheral nervous system neoplasm	0.000215	0.0024	CbGpPWpGaD
Topiramate—CA12—Metabolism—NME1—peripheral nervous system neoplasm	0.000207	0.00231	CbGpPWpGaD
Topiramate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000203	0.00227	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000201	0.00225	CbGpPWpGaD
Topiramate—CA12—Metabolism—COX2—peripheral nervous system neoplasm	0.000199	0.00223	CbGpPWpGaD
Topiramate—GRIA4—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000198	0.00221	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	0.000197	0.0022	CbGpPWpGaD
Topiramate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000193	0.00216	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000193	0.00215	CbGpPWpGaD
Topiramate—CA9—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000192	0.00215	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000188	0.0021	CbGpPWpGaD
Topiramate—GRIA3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000187	0.0021	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000187	0.00209	CbGpPWpGaD
Topiramate—CA9—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	0.000185	0.00207	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000179	0.002	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000176	0.00197	CbGpPWpGaD
Topiramate—CA4—Metabolism—GNS—peripheral nervous system neoplasm	0.000172	0.00192	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000171	0.00191	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—MET—peripheral nervous system neoplasm	0.00017	0.0019	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	0.000167	0.00186	CbGpPWpGaD
Topiramate—CA2—Metabolism—GNS—peripheral nervous system neoplasm	0.000165	0.00184	CbGpPWpGaD
Topiramate—CA4—Metabolism—NME1—peripheral nervous system neoplasm	0.000165	0.00184	CbGpPWpGaD
Topiramate—CA4—Metabolism—COX2—peripheral nervous system neoplasm	0.000159	0.00178	CbGpPWpGaD
Topiramate—CA1—Metabolism—GNS—peripheral nervous system neoplasm	0.000158	0.00177	CbGpPWpGaD
Topiramate—CA2—Metabolism—NME1—peripheral nervous system neoplasm	0.000158	0.00177	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000157	0.00176	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000154	0.00172	CbGpPWpGaD
Topiramate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000153	0.000221	CcSEcCtD
Topiramate—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000152	0.000221	CcSEcCtD
Topiramate—CA2—Metabolism—COX2—peripheral nervous system neoplasm	0.000152	0.0017	CbGpPWpGaD
Topiramate—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.00022	CcSEcCtD
Topiramate—CA1—Metabolism—NME1—peripheral nervous system neoplasm	0.000152	0.0017	CbGpPWpGaD
Topiramate—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000219	CcSEcCtD
Topiramate—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000151	0.000219	CcSEcCtD
Topiramate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000151	0.000219	CcSEcCtD
Topiramate—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000151	0.000219	CcSEcCtD
Topiramate—CA5A—Metabolism—ENO2—peripheral nervous system neoplasm	0.000151	0.00169	CbGpPWpGaD
Topiramate—CA6—Metabolism—ENO2—peripheral nervous system neoplasm	0.000151	0.00169	CbGpPWpGaD
Topiramate—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000219	CcSEcCtD
Topiramate—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000217	CcSEcCtD
Topiramate—Pain—Etoposide—peripheral nervous system neoplasm	0.00015	0.000217	CcSEcCtD
Topiramate—Constipation—Etoposide—peripheral nervous system neoplasm	0.00015	0.000217	CcSEcCtD
Topiramate—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000217	CcSEcCtD
Topiramate—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000217	CcSEcCtD
Topiramate—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000217	CcSEcCtD
Topiramate—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000217	CcSEcCtD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000149	0.00167	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000149	0.00167	CbGpPWpGaD
Topiramate—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000215	CcSEcCtD
Topiramate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000149	0.000215	CcSEcCtD
Topiramate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000148	0.000214	CcSEcCtD
Topiramate—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000214	CcSEcCtD
Topiramate—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000213	CcSEcCtD
Topiramate—GRIA1—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	0.000146	0.00163	CbGpPWpGaD
Topiramate—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000211	CcSEcCtD
Topiramate—CA1—Metabolism—COX2—peripheral nervous system neoplasm	0.000146	0.00163	CbGpPWpGaD
Topiramate—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000211	CcSEcCtD
Topiramate—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000145	0.00021	CcSEcCtD
Topiramate—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000209	CcSEcCtD
Topiramate—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000209	CcSEcCtD
Topiramate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000144	0.000209	CcSEcCtD
Topiramate—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000209	CcSEcCtD
Topiramate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000144	0.000208	CcSEcCtD
Topiramate—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000208	CcSEcCtD
Topiramate—GRIA3—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000144	0.00161	CbGpPWpGaD
Topiramate—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000208	CcSEcCtD
Topiramate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000143	0.000208	CcSEcCtD
Topiramate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000143	0.000207	CcSEcCtD
Topiramate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000143	0.000207	CcSEcCtD
Topiramate—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000206	CcSEcCtD
Topiramate—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000206	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000142	0.00159	CbGpPWpGaD
Topiramate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000142	0.000205	CcSEcCtD
Topiramate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000142	0.000205	CcSEcCtD
Topiramate—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000205	CcSEcCtD
Topiramate—CA5B—Metabolism—ENO2—peripheral nervous system neoplasm	0.000141	0.00158	CbGpPWpGaD
Topiramate—CA7—Metabolism—ENO2—peripheral nervous system neoplasm	0.000141	0.00158	CbGpPWpGaD
Topiramate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000141	0.000204	CcSEcCtD
Topiramate—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000204	CcSEcCtD
Topiramate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000141	0.000204	CcSEcCtD
Topiramate—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000203	CcSEcCtD
Topiramate—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000202	CcSEcCtD
Topiramate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000139	0.000202	CcSEcCtD
Topiramate—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000201	CcSEcCtD
Topiramate—CA9—Metabolism—GNS—peripheral nervous system neoplasm	0.000139	0.00155	CbGpPWpGaD
Topiramate—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000201	CcSEcCtD
Topiramate—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000201	CcSEcCtD
Topiramate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000139	0.000201	CcSEcCtD
Topiramate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000139	0.000201	CcSEcCtD
Topiramate—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000201	CcSEcCtD
Topiramate—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000201	CcSEcCtD
Topiramate—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000138	0.0002	CcSEcCtD
Topiramate—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000138	0.0002	CcSEcCtD
Topiramate—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000199	CcSEcCtD
Topiramate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000138	0.000199	CcSEcCtD
Topiramate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000137	0.000199	CcSEcCtD
Topiramate—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000199	CcSEcCtD
Topiramate—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000198	CcSEcCtD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000137	0.00153	CbGpPWpGaD
Topiramate—Rash—Vincristine—peripheral nervous system neoplasm	0.000136	0.000198	CcSEcCtD
Topiramate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000136	0.000197	CcSEcCtD
Topiramate—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000197	CcSEcCtD
Topiramate—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000197	CcSEcCtD
Topiramate—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000197	CcSEcCtD
Topiramate—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000196	CcSEcCtD
Topiramate—Headache—Vincristine—peripheral nervous system neoplasm	0.000136	0.000196	CcSEcCtD
Topiramate—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000195	CcSEcCtD
Topiramate—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000194	CcSEcCtD
Topiramate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000133	0.000193	CcSEcCtD
Topiramate—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000193	CcSEcCtD
Topiramate—CA9—Metabolism—NME1—peripheral nervous system neoplasm	0.000133	0.00149	CbGpPWpGaD
Topiramate—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000193	CcSEcCtD
Topiramate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000131	0.00019	CcSEcCtD
Topiramate—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000189	CcSEcCtD
Topiramate—CA12—Metabolism—ENO2—peripheral nervous system neoplasm	0.000131	0.00146	CbGpPWpGaD
Topiramate—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000189	CcSEcCtD
Topiramate—CA9—Cellular responses to stress—CDKN2A—peripheral nervous system neoplasm	0.00013	0.00146	CbGpPWpGaD
Topiramate—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000187	CcSEcCtD
Topiramate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000129	0.000187	CcSEcCtD
Topiramate—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000187	CcSEcCtD
Topiramate—GRIA1—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	0.000129	0.00144	CbGpPWpGaD
Topiramate—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000186	CcSEcCtD
Topiramate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000129	0.000186	CcSEcCtD
Topiramate—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000186	CcSEcCtD
Topiramate—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000186	CcSEcCtD
Topiramate—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000186	CcSEcCtD
Topiramate—CA9—Metabolism—COX2—peripheral nervous system neoplasm	0.000128	0.00143	CbGpPWpGaD
Topiramate—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000185	CcSEcCtD
Topiramate—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000185	CcSEcCtD
Topiramate—CA5A—Metabolism—BCHE—peripheral nervous system neoplasm	0.000128	0.00143	CbGpPWpGaD
Topiramate—CA6—Metabolism—BCHE—peripheral nervous system neoplasm	0.000128	0.00143	CbGpPWpGaD
Topiramate—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000184	CcSEcCtD
Topiramate—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000184	CcSEcCtD
Topiramate—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000183	CcSEcCtD
Topiramate—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000183	CcSEcCtD
Topiramate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000126	0.000182	CcSEcCtD
Topiramate—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000182	CcSEcCtD
Topiramate—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000182	CcSEcCtD
Topiramate—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000182	CcSEcCtD
Topiramate—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000181	CcSEcCtD
Topiramate—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000181	CcSEcCtD
Topiramate—SCN1A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000124	0.00139	CbGpPWpGaD
Topiramate—Chills—Epirubicin—peripheral nervous system neoplasm	0.000124	0.00018	CcSEcCtD
Topiramate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000124	0.00018	CcSEcCtD
Topiramate—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000179	CcSEcCtD
Topiramate—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000177	CcSEcCtD
Topiramate—CA5A—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000122	0.00136	CbGpPWpGaD
Topiramate—CA6—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000122	0.00136	CbGpPWpGaD
Topiramate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000122	0.000176	CcSEcCtD
Topiramate—SCN1A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000121	0.00136	CbGpPWpGaD
Topiramate—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000175	CcSEcCtD
Topiramate—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000175	CcSEcCtD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000121	0.00135	CbGpPWpGaD
Topiramate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000121	0.000175	CcSEcCtD
Topiramate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000121	0.000175	CcSEcCtD
Topiramate—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000174	CcSEcCtD
Topiramate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000174	CcSEcCtD
Topiramate—CA5A—Metabolism—TH—peripheral nervous system neoplasm	0.00012	0.00134	CbGpPWpGaD
Topiramate—CA6—Metabolism—TH—peripheral nervous system neoplasm	0.00012	0.00134	CbGpPWpGaD
Topiramate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00012	0.000174	CcSEcCtD
Topiramate—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000173	CcSEcCtD
Topiramate—SCN5A—Axon guidance—MET—peripheral nervous system neoplasm	0.00012	0.00134	CbGpPWpGaD
Topiramate—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000173	CcSEcCtD
Topiramate—CA5B—Metabolism—BCHE—peripheral nervous system neoplasm	0.000119	0.00133	CbGpPWpGaD
Topiramate—CA7—Metabolism—BCHE—peripheral nervous system neoplasm	0.000119	0.00133	CbGpPWpGaD
Topiramate—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000172	CcSEcCtD
Topiramate—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000172	CcSEcCtD
Topiramate—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000172	CcSEcCtD
Topiramate—Tension—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000171	CcSEcCtD
Topiramate—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000171	CcSEcCtD
Topiramate—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000169	CcSEcCtD
Topiramate—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000169	CcSEcCtD
Topiramate—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000168	CcSEcCtD
Topiramate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000116	0.000168	CcSEcCtD
Topiramate—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000168	CcSEcCtD
Topiramate—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000167	CcSEcCtD
Topiramate—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000167	CcSEcCtD
Topiramate—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000166	CcSEcCtD
Topiramate—CA5B—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000114	0.00127	CbGpPWpGaD
Topiramate—CA7—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000114	0.00127	CbGpPWpGaD
Topiramate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000114	0.000165	CcSEcCtD
Topiramate—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000164	CcSEcCtD
Topiramate—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000164	CcSEcCtD
Topiramate—GRIA1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000112	0.00126	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000112	0.00125	CbGpPWpGaD
Topiramate—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000162	CcSEcCtD
Topiramate—CA5B—Metabolism—TH—peripheral nervous system neoplasm	0.000112	0.00125	CbGpPWpGaD
Topiramate—CA7—Metabolism—TH—peripheral nervous system neoplasm	0.000112	0.00125	CbGpPWpGaD
Topiramate—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000162	CcSEcCtD
Topiramate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000111	0.000161	CcSEcCtD
Topiramate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000161	CcSEcCtD
Topiramate—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000161	CcSEcCtD
Topiramate—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000161	CcSEcCtD
Topiramate—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000111	0.00016	CcSEcCtD
Topiramate—SCN5A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000111	0.00124	CbGpPWpGaD
Topiramate—Rash—Etoposide—peripheral nervous system neoplasm	0.000111	0.00016	CcSEcCtD
Topiramate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00011	0.00016	CcSEcCtD
Topiramate—CA12—Metabolism—BCHE—peripheral nervous system neoplasm	0.00011	0.00123	CbGpPWpGaD
Topiramate—Headache—Etoposide—peripheral nervous system neoplasm	0.00011	0.000159	CcSEcCtD
Topiramate—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000159	CcSEcCtD
Topiramate—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000158	CcSEcCtD
Topiramate—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000158	CcSEcCtD
Topiramate—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000157	CcSEcCtD
Topiramate—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000157	CcSEcCtD
Topiramate—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000157	CcSEcCtD
Topiramate—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000156	CcSEcCtD
Topiramate—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000156	CcSEcCtD
Topiramate—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000156	CcSEcCtD
Topiramate—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000155	CcSEcCtD
Topiramate—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000154	CcSEcCtD
Topiramate—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000153	CcSEcCtD
Topiramate—CA12—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000105	0.00118	CbGpPWpGaD
Topiramate—Cough—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000152	CcSEcCtD
Topiramate—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000152	CcSEcCtD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000104	0.00117	CbGpPWpGaD
Topiramate—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000151	CcSEcCtD
Topiramate—CA4—Metabolism—ENO2—peripheral nervous system neoplasm	0.000104	0.00117	CbGpPWpGaD
Topiramate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000104	0.000151	CcSEcCtD
Topiramate—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000151	CcSEcCtD
Topiramate—CA12—Metabolism—TH—peripheral nervous system neoplasm	0.000104	0.00116	CbGpPWpGaD
Topiramate—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.00015	CcSEcCtD
Topiramate—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000149	CcSEcCtD
Topiramate—GRIK2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000103	0.00115	CbGpPWpGaD
Topiramate—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000148	CcSEcCtD
Topiramate—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000148	CcSEcCtD
Topiramate—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000148	CcSEcCtD
Topiramate—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000148	CcSEcCtD
Topiramate—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000148	CcSEcCtD
Topiramate—GRIA2—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	0.000102	0.00114	CbGpPWpGaD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000147	CcSEcCtD
Topiramate—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000147	CcSEcCtD
Topiramate—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000145	CcSEcCtD
Topiramate—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000145	CcSEcCtD
Topiramate—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000145	CcSEcCtD
Topiramate—Syncope—Doxorubicin—peripheral nervous system neoplasm	9.99e-05	0.000145	CcSEcCtD
Topiramate—CA2—Metabolism—ENO2—peripheral nervous system neoplasm	9.99e-05	0.00112	CbGpPWpGaD
Topiramate—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	9.97e-05	0.000144	CcSEcCtD
Topiramate—Confusional state—Epirubicin—peripheral nervous system neoplasm	9.91e-05	0.000143	CcSEcCtD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	9.88e-05	0.0011	CbGpPWpGaD
Topiramate—Palpitations—Doxorubicin—peripheral nervous system neoplasm	9.85e-05	0.000143	CcSEcCtD
Topiramate—Oedema—Epirubicin—peripheral nervous system neoplasm	9.83e-05	0.000142	CcSEcCtD
Topiramate—CA5A—Metabolism—GNAS—peripheral nervous system neoplasm	9.8e-05	0.0011	CbGpPWpGaD
Topiramate—CA6—Metabolism—GNAS—peripheral nervous system neoplasm	9.8e-05	0.0011	CbGpPWpGaD
Topiramate—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	9.79e-05	0.000142	CcSEcCtD
Topiramate—Infection—Epirubicin—peripheral nervous system neoplasm	9.76e-05	0.000141	CcSEcCtD
Topiramate—Cough—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000141	CcSEcCtD
Topiramate—Shock—Epirubicin—peripheral nervous system neoplasm	9.67e-05	0.00014	CcSEcCtD
Topiramate—Convulsion—Doxorubicin—peripheral nervous system neoplasm	9.66e-05	0.00014	CcSEcCtD
Topiramate—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	9.64e-05	0.00014	CcSEcCtD
Topiramate—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	9.62e-05	0.000139	CcSEcCtD
Topiramate—Hypertension—Doxorubicin—peripheral nervous system neoplasm	9.62e-05	0.000139	CcSEcCtD
Topiramate—CA6—Metabolism—ABCB1—peripheral nervous system neoplasm	9.62e-05	0.00108	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ABCB1—peripheral nervous system neoplasm	9.62e-05	0.00108	CbGpPWpGaD
Topiramate—Tachycardia—Epirubicin—peripheral nervous system neoplasm	9.59e-05	0.000139	CcSEcCtD
Topiramate—CA1—Metabolism—ENO2—peripheral nervous system neoplasm	9.58e-05	0.00107	CbGpPWpGaD
Topiramate—Skin disorder—Epirubicin—peripheral nervous system neoplasm	9.55e-05	0.000138	CcSEcCtD
Topiramate—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	9.5e-05	0.000138	CcSEcCtD
Topiramate—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	9.49e-05	0.000137	CcSEcCtD
Topiramate—Myalgia—Doxorubicin—peripheral nervous system neoplasm	9.49e-05	0.000137	CcSEcCtD
Topiramate—Chest pain—Doxorubicin—peripheral nervous system neoplasm	9.49e-05	0.000137	CcSEcCtD
Topiramate—SCN1A—Axon guidance—NRAS—peripheral nervous system neoplasm	9.46e-05	0.00106	CbGpPWpGaD
Topiramate—Anxiety—Doxorubicin—peripheral nervous system neoplasm	9.45e-05	0.000137	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	9.42e-05	0.000136	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	9.38e-05	0.00105	CbGpPWpGaD
Topiramate—Discomfort—Doxorubicin—peripheral nervous system neoplasm	9.37e-05	0.000136	CcSEcCtD
Topiramate—Anorexia—Epirubicin—peripheral nervous system neoplasm	9.37e-05	0.000136	CcSEcCtD
Topiramate—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	9.28e-05	0.000134	CcSEcCtD
Topiramate—Hypotension—Epirubicin—peripheral nervous system neoplasm	9.18e-05	0.000133	CcSEcCtD
Topiramate—Confusional state—Doxorubicin—peripheral nervous system neoplasm	9.17e-05	0.000133	CcSEcCtD
Topiramate—CA7—Metabolism—GNAS—peripheral nervous system neoplasm	9.15e-05	0.00102	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GNAS—peripheral nervous system neoplasm	9.15e-05	0.00102	CbGpPWpGaD
Topiramate—Oedema—Doxorubicin—peripheral nervous system neoplasm	9.09e-05	0.000132	CcSEcCtD
Topiramate—Infection—Doxorubicin—peripheral nervous system neoplasm	9.04e-05	0.000131	CcSEcCtD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	9.03e-05	0.00101	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	9.02e-05	0.00101	CbGpPWpGaD
Topiramate—CA7—Metabolism—ABCB1—peripheral nervous system neoplasm	8.98e-05	0.001	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ABCB1—peripheral nervous system neoplasm	8.98e-05	0.001	CbGpPWpGaD
Topiramate—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	8.96e-05	0.00013	CcSEcCtD
Topiramate—Shock—Doxorubicin—peripheral nervous system neoplasm	8.95e-05	0.00013	CcSEcCtD
Topiramate—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	8.92e-05	0.000129	CcSEcCtD
Topiramate—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	8.9e-05	0.000129	CcSEcCtD
Topiramate—Insomnia—Epirubicin—peripheral nervous system neoplasm	8.89e-05	0.000129	CcSEcCtD
Topiramate—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	8.88e-05	0.000129	CcSEcCtD
Topiramate—SCN1A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	8.87e-05	0.000992	CbGpPWpGaD
Topiramate—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	8.83e-05	0.000128	CcSEcCtD
Topiramate—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	8.83e-05	0.000128	CcSEcCtD
Topiramate—CA4—Metabolism—BCHE—peripheral nervous system neoplasm	8.81e-05	0.000985	CbGpPWpGaD
Topiramate—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	8.79e-05	0.000127	CcSEcCtD
Topiramate—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	8.76e-05	0.000127	CcSEcCtD
Topiramate—SCN5A—Axon guidance—ERBB2—peripheral nervous system neoplasm	8.74e-05	0.000977	CbGpPWpGaD
Topiramate—Somnolence—Epirubicin—peripheral nervous system neoplasm	8.74e-05	0.000127	CcSEcCtD
Topiramate—Anorexia—Doxorubicin—peripheral nervous system neoplasm	8.67e-05	0.000126	CcSEcCtD
Topiramate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	8.65e-05	0.000125	CcSEcCtD
Topiramate—GRIA1—Neuronal System—HRAS—peripheral nervous system neoplasm	8.6e-05	0.000962	CbGpPWpGaD
Topiramate—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	8.54e-05	0.000124	CcSEcCtD
Topiramate—SCN5A—Developmental Biology—MET—peripheral nervous system neoplasm	8.53e-05	0.000954	CbGpPWpGaD
Topiramate—Hypotension—Doxorubicin—peripheral nervous system neoplasm	8.5e-05	0.000123	CcSEcCtD
Topiramate—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	8.49e-05	0.000123	CcSEcCtD
Topiramate—CA12—Metabolism—GNAS—peripheral nervous system neoplasm	8.48e-05	0.000948	CbGpPWpGaD
Topiramate—Fatigue—Epirubicin—peripheral nervous system neoplasm	8.47e-05	0.000123	CcSEcCtD
Topiramate—CA2—Metabolism—BCHE—peripheral nervous system neoplasm	8.44e-05	0.000944	CbGpPWpGaD
Topiramate—CA9—Metabolism—ENO2—peripheral nervous system neoplasm	8.42e-05	0.000942	CbGpPWpGaD
Topiramate—Pain—Epirubicin—peripheral nervous system neoplasm	8.41e-05	0.000122	CcSEcCtD
Topiramate—Constipation—Epirubicin—peripheral nervous system neoplasm	8.41e-05	0.000122	CcSEcCtD
Topiramate—CA4—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.4e-05	0.000939	CbGpPWpGaD
Topiramate—CA12—Metabolism—ABCB1—peripheral nervous system neoplasm	8.32e-05	0.00093	CbGpPWpGaD
Topiramate—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	8.29e-05	0.00012	CcSEcCtD
Topiramate—CA4—Metabolism—TH—peripheral nervous system neoplasm	8.28e-05	0.000926	CbGpPWpGaD
Topiramate—Insomnia—Doxorubicin—peripheral nervous system neoplasm	8.23e-05	0.000119	CcSEcCtD
Topiramate—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	8.17e-05	0.000118	CcSEcCtD
Topiramate—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	8.11e-05	0.000117	CcSEcCtD
Topiramate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.1e-05	0.000117	CcSEcCtD
Topiramate—CA1—Metabolism—BCHE—peripheral nervous system neoplasm	8.09e-05	0.000905	CbGpPWpGaD
Topiramate—Somnolence—Doxorubicin—peripheral nervous system neoplasm	8.09e-05	0.000117	CcSEcCtD
Topiramate—CA2—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.05e-05	0.000901	CbGpPWpGaD
Topiramate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.04e-05	0.000116	CcSEcCtD
Topiramate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	8.01e-05	0.000116	CcSEcCtD
Topiramate—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.97e-05	0.000891	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	7.95e-05	0.000889	CbGpPWpGaD
Topiramate—CA2—Metabolism—TH—peripheral nervous system neoplasm	7.94e-05	0.000888	CbGpPWpGaD
Topiramate—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	7.91e-05	0.000114	CcSEcCtD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	7.9e-05	0.000883	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	7.89e-05	0.000882	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—HRAS—peripheral nervous system neoplasm	7.87e-05	0.00088	CbGpPWpGaD
Topiramate—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.85e-05	0.000114	CcSEcCtD
Topiramate—GRIA2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	7.85e-05	0.000878	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	7.84e-05	0.000877	CbGpPWpGaD
Topiramate—Fatigue—Doxorubicin—peripheral nervous system neoplasm	7.84e-05	0.000114	CcSEcCtD
Topiramate—Urticaria—Epirubicin—peripheral nervous system neoplasm	7.81e-05	0.000113	CcSEcCtD
Topiramate—GABRB2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	7.8e-05	0.000872	CbGpPWpGaD
Topiramate—Pain—Doxorubicin—peripheral nervous system neoplasm	7.78e-05	0.000113	CcSEcCtD
Topiramate—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.78e-05	0.000113	CcSEcCtD
Topiramate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.77e-05	0.000112	CcSEcCtD
Topiramate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	7.77e-05	0.000112	CcSEcCtD
Topiramate—CA1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.72e-05	0.000863	CbGpPWpGaD
Topiramate—CA1—Metabolism—TH—peripheral nervous system neoplasm	7.61e-05	0.000851	CbGpPWpGaD
Topiramate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.49e-05	0.000108	CcSEcCtD
Topiramate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.44e-05	0.000108	CcSEcCtD
Topiramate—GABRG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	7.27e-05	0.000813	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—TP53—peripheral nervous system neoplasm	7.25e-05	0.00081	CbGpPWpGaD
Topiramate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.24e-05	0.000105	CcSEcCtD
Topiramate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.22e-05	0.000105	CcSEcCtD
Topiramate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.19e-05	0.000104	CcSEcCtD
Topiramate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.19e-05	0.000104	CcSEcCtD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	7.17e-05	0.000802	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	7.13e-05	0.000797	CbGpPWpGaD
Topiramate—CA9—Metabolism—BCHE—peripheral nervous system neoplasm	7.12e-05	0.000796	CbGpPWpGaD
Topiramate—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.05e-05	0.000102	CcSEcCtD
Topiramate—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.95e-05	0.000101	CcSEcCtD
Topiramate—SCN1A—Axon guidance—HRAS—peripheral nervous system neoplasm	6.92e-05	0.000774	CbGpPWpGaD
Topiramate—CA9—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.79e-05	0.000759	CbGpPWpGaD
Topiramate—CA4—Metabolism—GNAS—peripheral nervous system neoplasm	6.76e-05	0.000756	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—NRAS—peripheral nervous system neoplasm	6.75e-05	0.000755	CbGpPWpGaD
Topiramate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.73e-05	9.74e-05	CcSEcCtD
Topiramate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.7e-05	9.7e-05	CcSEcCtD
Topiramate—CA9—Metabolism—TH—peripheral nervous system neoplasm	6.69e-05	0.000748	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—NRAS—peripheral nervous system neoplasm	6.65e-05	0.000743	CbGpPWpGaD
Topiramate—CA4—Metabolism—ABCB1—peripheral nervous system neoplasm	6.63e-05	0.000742	CbGpPWpGaD
Topiramate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.53e-05	9.45e-05	CcSEcCtD
Topiramate—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.5e-05	9.41e-05	CcSEcCtD
Topiramate—CA2—Metabolism—GNAS—peripheral nervous system neoplasm	6.48e-05	0.000725	CbGpPWpGaD
Topiramate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.43e-05	9.32e-05	CcSEcCtD
Topiramate—CA2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.36e-05	0.000711	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6.35e-05	0.00071	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	6.27e-05	0.000701	CbGpPWpGaD
Topiramate—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.25e-05	9.05e-05	CcSEcCtD
Topiramate—SCN5A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	6.24e-05	0.000697	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.23e-05	0.000697	CbGpPWpGaD
Topiramate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.22e-05	9.01e-05	CcSEcCtD
Topiramate—CA1—Metabolism—GNAS—peripheral nervous system neoplasm	6.21e-05	0.000695	CbGpPWpGaD
Topiramate—Rash—Epirubicin—peripheral nervous system neoplasm	6.2e-05	8.97e-05	CcSEcCtD
Topiramate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.19e-05	8.96e-05	CcSEcCtD
Topiramate—Headache—Epirubicin—peripheral nervous system neoplasm	6.16e-05	8.91e-05	CcSEcCtD
Topiramate—CA1—Metabolism—ABCB1—peripheral nervous system neoplasm	6.1e-05	0.000682	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—HRAS—peripheral nervous system neoplasm	6.02e-05	0.000673	CbGpPWpGaD
Topiramate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.01e-05	8.71e-05	CcSEcCtD
Topiramate—GABRB2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	5.9e-05	0.000659	CbGpPWpGaD
Topiramate—Nausea—Epirubicin—peripheral nervous system neoplasm	5.84e-05	8.45e-05	CcSEcCtD
Topiramate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.78e-05	8.37e-05	CcSEcCtD
Topiramate—Rash—Doxorubicin—peripheral nervous system neoplasm	5.73e-05	8.3e-05	CcSEcCtD
Topiramate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.73e-05	8.29e-05	CcSEcCtD
Topiramate—Headache—Doxorubicin—peripheral nervous system neoplasm	5.7e-05	8.25e-05	CcSEcCtD
Topiramate—CA9—Metabolism—GNAS—peripheral nervous system neoplasm	5.46e-05	0.000611	CbGpPWpGaD
Topiramate—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.4e-05	7.82e-05	CcSEcCtD
Topiramate—GABRG2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	5.39e-05	0.000603	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.38e-05	0.000602	CbGpPWpGaD
Topiramate—CA9—Metabolism—ABCB1—peripheral nervous system neoplasm	5.36e-05	0.000599	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—HRAS—peripheral nervous system neoplasm	4.94e-05	0.000552	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—HRAS—peripheral nervous system neoplasm	4.86e-05	0.000544	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.79e-05	0.000536	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—NRAS—peripheral nervous system neoplasm	4.74e-05	0.00053	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	4.71e-05	0.000527	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—HRAS—peripheral nervous system neoplasm	4.52e-05	0.000505	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.47e-05	0.0005	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—AKT1—peripheral nervous system neoplasm	4.36e-05	0.000487	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—HRAS—peripheral nervous system neoplasm	4.13e-05	0.000462	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	3.89e-05	0.000435	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	3.73e-05	0.000417	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—HRAS—peripheral nervous system neoplasm	3.61e-05	0.000404	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	3.59e-05	0.000402	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—HRAS—peripheral nervous system neoplasm	3.47e-05	0.000388	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.24e-05	0.000362	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—AKT1—peripheral nervous system neoplasm	3.06e-05	0.000343	CbGpPWpGaD
Topiramate—CA5A—Metabolism—AKT1—peripheral nervous system neoplasm	2.65e-05	0.000296	CbGpPWpGaD
Topiramate—CA6—Metabolism—AKT1—peripheral nervous system neoplasm	2.65e-05	0.000296	CbGpPWpGaD
Topiramate—CA5B—Metabolism—AKT1—peripheral nervous system neoplasm	2.47e-05	0.000276	CbGpPWpGaD
Topiramate—CA7—Metabolism—AKT1—peripheral nervous system neoplasm	2.47e-05	0.000276	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	2.36e-05	0.000264	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	2.34e-05	0.000262	CbGpPWpGaD
Topiramate—CA12—Metabolism—AKT1—peripheral nervous system neoplasm	2.29e-05	0.000256	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	2.24e-05	0.000251	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	2.16e-05	0.000241	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	1.99e-05	0.000223	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.9e-05	0.000212	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	1.87e-05	0.000209	CbGpPWpGaD
Topiramate—CA4—Metabolism—AKT1—peripheral nervous system neoplasm	1.82e-05	0.000204	CbGpPWpGaD
Topiramate—CA2—Metabolism—AKT1—peripheral nervous system neoplasm	1.75e-05	0.000196	CbGpPWpGaD
Topiramate—CA1—Metabolism—AKT1—peripheral nervous system neoplasm	1.68e-05	0.000188	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	1.53e-05	0.000171	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	1.5e-05	0.000168	CbGpPWpGaD
Topiramate—CA9—Metabolism—AKT1—peripheral nervous system neoplasm	1.47e-05	0.000165	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.42e-05	0.000159	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.2e-05	0.000134	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.14e-05	0.000128	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.13e-05	0.000126	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	9.19e-06	0.000103	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	9.02e-06	0.000101	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	4.13e-06	4.61e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	2.48e-06	2.78e-05	CbGpPWpGaD
